EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries

Anna M Nordenskjöld iD, Lars Lindhagen, Björn Wettermark iD, Bertil Lindahl

PLOS One · 29.05.2025 · 20 (5) · e0324533

DOI: 10.1371/journal.pone.0324533 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS One, online erschienen am 29.05.2025. Verfasst von Anna M Nordenskjöld und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Hauptthemen laut MEDLINE: Myocardial Infarction, Secondary Prevention, Coronary Artery Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Foundation for MS Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Poor adherence to secondary preventive medication after myocardial infarction (MI) negatively affects long-term prognosis, but knowledge is lacking regarding the impact of poor adherence on prognosis for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA). We therefore investigated the effect of persistence to secondary preventive medication on prognosis in patients with MINOCA compared with patients with myocardial infarction with obstructive coronary arteries (MI-CAD).

Methods

In this nationwide observational study of 116,143 patients with MI recorded in the SWEDEHEART registry between 2006─2017, MINOCA were identified in 9,124 patients and MI-CAD in 107,019 patients. Persistence to treatment with aspirin, statins, beta blockers and angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARBs) was investigated for 5 years post discharge and patients were followed for a composite endpoint of major adverse cardiovascular events (MACE), including all-cause death, MI, ischemic stroke and heart failure.

Results

Persistent use of secondary preventive medications was associated with a decrease in the risk of MACE during follow-up in both MINOCA and MI-CAD patients; aspirin HR 0.70 (CI 0.60–0.82) vs. HR 0.60 (CI 0.57–0.64), statins HR 0.80 (CI 0.68–0.95) vs. HR 0.66 (CI 0.63–0.69), beta blockers HR 0.77 (CI 0.65–0.92) vs. HR 0.76 (CI 0.73–0.80) and ACEIs/ARBs HR 0.62 (CI 0.50–0.77) vs. 0.67 (CI 0.63–0.71).

Conclusion

Persistence to secondary preventive medications after MI is associated with a reduction in the risk for MACE in both patients with MINOCA and MI-CAD. Continuous efforts to improve adherence to evidence-based medications in general to all patients with MI should be a priority.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionSecondary PreventionCoronary Artery DiseaseHumansFemaleMaleAgedPrognosisMiddle AgedAngiotensin-Converting Enzyme InhibitorsAspirinHydroxymethylglutaryl-CoA Reductase InhibitorsAdrenergic beta-AntagonistsRegistriesAngiotensin Receptor AntagonistsCoronary Vessels

Substanzen

Angiotensin-Converting Enzyme InhibitorsAspirinHydroxymethylglutaryl-CoA Reductase InhibitorsAdrenergic beta-AntagonistsAngiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Department of Cardiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Department of Pharmacy, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

ORCID-Profile: Anna M Nordenskjöld, Björn Wettermark

Förderung

  • Swedish Foundation for MS Research

Zitieren

APA

Nordenskjöld, A. M., Lindhagen, L., Wettermark, B., & Lindahl, B. (2025). Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries. PLOS One, 20(5), e0324533. https://doi.org/10.1371/journal.pone.0324533

Vancouver

Nordenskjöld AM, Lindhagen L, Wettermark B, Lindahl B. Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries. PLOS One. 2025;20(5):e0324533. doi:10.1371/journal.pone.0324533

BibTeX
@article{Nordenskjld2025,
  author = {Nordenskjöld, Anna M and Lindhagen, Lars and Wettermark, Björn and Lindahl, Bertil},
  title = {Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries},
  journal = {PLOS One},
  year = {2025},
  volume = {20},
  number = {5},
  pages = {e0324533},
  doi = {10.1371/journal.pone.0324533}
}
Kostenlos starten →